Results hosted on duckduckgo.com
Register here to receive our news releases
Register here to receive our newsletter
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:
Media relations and corporate communication
Email: Kathy Robertson
Tel: (351) 211 21 02 00/32
Mobile. (351) 935 994 027
Hepatitis C and injecting drug use: impact, costs and policy options
2004 Annual report: 'Selected issues'
2004 Annual report: 10 years of reporting
2004 Annual report: highlights
2004 Annual report from the EU drugs agency
Evaluation of the EU strategy and action plan on drugs (2000 –2004)
Evaluation of the EU strategy and action plan on drugs (2000-2004)
New feature on ELDD offers easy access to EU drug legislation
New online pool of national drug information
Drug treatment now more available, accessible and diverse
New EMCDDA study asks ‘Is cannabis getting stronger?’
The way forward for EU action against drugs
Russian delegation visits EU drugs agency
Upcoming changes at EU drugs agency
Hepatitis C — the 'hidden epidemic'
‘A hidden epidemic’ and ‘a major challenge to public health’ – this is how the EU drugs agency, the Lisbon-based EMCDDA, describes hepatitis C in the latest edition of its Drugs in focus series, out today.